Cargando…
High-Throughput CRISPR Screening in Hematological Neoplasms
SIMPLE SUMMARY: High-throughput CRISPR screening provides an unbiased way for functional genomic studies in hematological malignancies. This approach has been used to study different blood cancers aiming to identify modulator genes for drug efficacy, therapeutic targets, synthetic lethal interaction...
Autores principales: | Ancos-Pintado, Raquel, Bragado-García, Irene, Morales, María Luz, García-Vicente, Roberto, Arroyo-Barea, Andrés, Rodríguez-García, Alba, Martínez-López, Joaquín, Linares, María, Hernández-Sánchez, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329962/ https://www.ncbi.nlm.nih.gov/pubmed/35892871 http://dx.doi.org/10.3390/cancers14153612 |
Ejemplares similares
-
Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies
por: Rodríguez-García, Alba, et al.
Publicado: (2020) -
P850: THE EFFECT OF UROLITHIN PRODUCTION BY GUT MICROBIOTA IN MULTIPLE MYELOMA
por: Rodríguez-García, Alba, et al.
Publicado: (2023) -
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy
por: Rodríguez-García, Alba, et al.
Publicado: (2019) -
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms
por: Cortés, Alicia Arenas, et al.
Publicado: (2019) -
Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)